March 14, 2012
University of Minnesota, Mayo Project Wins Biotech Grant
The Minnesota Partnership for Biotechnology and Medical Genomics has awarded $1.35 million to University of Minnesota and Mayo Clinic researchers seeking new treatments for myelodysplastic syndrome (MDS), a cancer of the blood that impacts the way the human body develops blood cells. The grant will help support the development of pilot studies that could someday […]
Tags: Minnesota Partnership for Biotechnology and Medical Genomics, Myelodysplatic Syndrome, University of Minnesota